(a) 5-year mortality between Q1 to Q5 | Percentage point difference | ||
RR | DR | CR | |
All cancers combined | –4% | −5% | 1%a |
Colorectal | −5% | −4% | −6% |
Lung | −5% | −2%a | 0%a |
Breast | −4% | 3%a | −2%a |
Prostate | −12% | −4% | −10% |
(b) Odds of late- versus early-stage cancers at diagnosis between Q1 to Q5 | |||
RR | DR | CR | |
All cancers combined | −3% | −4% | −2% |
Colorectal | −1%a | 3%a | −3%a |
Lung | −8% | 2%a | 0%a |
Breast | −5% | 14% | 0%a |
Prostate | −9% | 8% | −9% |
(c) 5-year mortality between Q1 to Q5 taking stage into account | |||
RR | DR | CR | |
All cancers combined | −2% | −3% | 5% |
Colorectal | −6% | −4% | −2%a |
Lung | −3% | −2%a | 3% |
Breast | 0%a | 3%a | 3%a |
Prostate | −8% | −4% | −4% |
↵a No statistically significant trend over quintiles. CR = conversion ratio. DR = detection ratio. RR = referral ratio.